Home/Filings/4/0001415889-24-014689
4//SEC Filing

Zojwalla Naseem 4

Accession 0001415889-24-014689

CIK 0001750284other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 5:00 PM ET

Size

7.0 KB

Accession

0001415889-24-014689

Insider Transaction Report

Form 4
Period: 2024-05-24
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-249,460126,840 total
    Exercise: $4.87Exp: 2033-01-31Common Stock (9,460 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-24$4.87/sh+9,460$46,07089,824 total
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001905871

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 5:00 PM ET
Size
7.0 KB